The global Extracellular Vesicle Therapy market was valued at 750 million in 2023 and is projected to reach US$ 1566 million by 2030, at a CAGR of 11.3% during the forecast period.
Extracellular Vesicle Therapy refers to an emerging therapy that uses extracellular vesicles as a therapeutic approach. These extracellular vesicles are small vesicles released by cells that can carry a variety of biological molecules (such as proteins, lipids, and RNA) to transmit signals and exchange substances between cells.
The U.S. market is estimated at $ million in 2023, while China is to reach $ million.
Exosome-based segment will reach $ million by 2030, with a % CAGR in next six years.
The global key players of Extracellular Vesicle Therapy include FUJIFILM Diosynth Biotechnologies, EV Therapeutics, Cellular Biomedicine Group, Codiak BioSciences, Coya Therapeutics, Curexsys, Evox Therapeutics, ExoCoBio, ILIAS Biologics, Rion, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Extracellular Vesicle Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks
This report aims to provide a comprehensive presentation of the global market for Extracellular Vesicle Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Extracellular Vesicle Therapy. This report contains market size and forecasts of Extracellular Vesicle Therapy in global, including the following market information:
Global Extracellular Vesicle Therapy market revenue, 2019-2024, 2025-2030, ($ millions)
Global top five Extracellular Vesicle Therapy companies in 2023 (%)
Total Market by Segment:
Global Extracellular Vesicle Therapy market, by Type, 2019-2024, 2025-2030 ($ millions)
Global Extracellular Vesicle Therapy market segment percentages, by Type, 2023 (%)
Exosome-based
Microvesicle-based
Global Extracellular Vesicle Therapy market, by Application, 2019-2024, 2025-2030 ($ millions)
Global Extracellular Vesicle Therapy market segment percentages, by Application, 2023 (%)
Cancer Treatment
Regenerative Medicine
Drug Delivery
Other
Global Extracellular Vesicle Therapy market, by region and country, 2019-2024, 2025-2030 ($ millions)
Global Extracellular Vesicle Therapy market segment percentages, by region and country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Extracellular Vesicle Therapy revenues in global market, 2019-2024 (estimated), ($ millions)
Key companies Extracellular Vesicle Therapy revenues share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
FUJIFILM Diosynth Biotechnologies
EV Therapeutics
Cellular Biomedicine Group
Codiak BioSciences
Coya Therapeutics
Curexsys
Evox Therapeutics
ExoCoBio
ILIAS Biologics
Rion
SHIFTBIO
Outline of Major Chapters:
Chapter 1: Introduces the definition of Extracellular Vesicle Therapy, market overview.
Chapter 2: Global Extracellular Vesicle Therapy market size in revenue.
Chapter 3: Detailed analysis of Extracellular Vesicle Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Extracellular Vesicle Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Extracellular Vesicle Therapy Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 Global Extracellular Vesicle Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Extracellular Vesicle Therapy Overall Market Size
2.1 Global Extracellular Vesicle Therapy Market Size: 2023 VS 2030
2.2 Global Extracellular Vesicle Therapy Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Extracellular Vesicle Therapy Players in Global Market
3.2 Top Global Extracellular Vesicle Therapy Companies Ranked by Revenue
3.3 Global Extracellular Vesicle Therapy Revenue by Companies
3.4 Top 3 and Top 5 Extracellular Vesicle Therapy Companies in Global Market, by Revenue in 2023
3.5 Global Companies Extracellular Vesicle Therapy Product Type
3.6 Tier 1, Tier 2, and Tier 3 Extracellular Vesicle Therapy Players in Global Market
3.6.1 List of Global Tier 1 Extracellular Vesicle Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Extracellular Vesicle Therapy Companies
4 Sights by Product
4.1 Overview
4.1.1 Segmentation by Type - Global Extracellular Vesicle Therapy Market Size Markets, 2023 & 2030
4.1.2 Exosome-based
4.1.3 Microvesicle-based
4.2 Segmentation by Type - Global Extracellular Vesicle Therapy Revenue & Forecasts
4.2.1 Segmentation by Type - Global Extracellular Vesicle Therapy Revenue, 2019-2024
4.2.2 Segmentation by Type - Global Extracellular Vesicle Therapy Revenue, 2025-2030
4.2.3 Segmentation by Type - Global Extracellular Vesicle Therapy Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 Segmentation by Application - Global Extracellular Vesicle Therapy Market Size, 2023 & 2030
5.1.2 Cancer Treatment
5.1.3 Regenerative Medicine
5.1.4 Drug Delivery
5.1.5 Other
5.2 Segmentation by Application - Global Extracellular Vesicle Therapy Revenue & Forecasts
5.2.1 Segmentation by Application - Global Extracellular Vesicle Therapy Revenue, 2019-2024
5.2.2 Segmentation by Application - Global Extracellular Vesicle Therapy Revenue, 2025-2030
5.2.3 Segmentation by Application - Global Extracellular Vesicle Therapy Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Extracellular Vesicle Therapy Market Size, 2023 & 2030
6.2 By Region - Global Extracellular Vesicle Therapy Revenue & Forecasts
6.2.1 By Region - Global Extracellular Vesicle Therapy Revenue, 2019-2024
6.2.2 By Region - Global Extracellular Vesicle Therapy Revenue, 2025-2030
6.2.3 By Region - Global Extracellular Vesicle Therapy Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Extracellular Vesicle Therapy Revenue, 2019-2030
6.3.2 United States Extracellular Vesicle Therapy Market Size, 2019-2030
6.3.3 Canada Extracellular Vesicle Therapy Market Size, 2019-2030
6.3.4 Mexico Extracellular Vesicle Therapy Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Extracellular Vesicle Therapy Revenue, 2019-2030
6.4.2 Germany Extracellular Vesicle Therapy Market Size, 2019-2030
6.4.3 France Extracellular Vesicle Therapy Market Size, 2019-2030
6.4.4 U.K. Extracellular Vesicle Therapy Market Size, 2019-2030
6.4.5 Italy Extracellular Vesicle Therapy Market Size, 2019-2030
6.4.6 Russia Extracellular Vesicle Therapy Market Size, 2019-2030
6.4.7 Nordic Countries Extracellular Vesicle Therapy Market Size, 2019-2030
6.4.8 Benelux Extracellular Vesicle Therapy Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Extracellular Vesicle Therapy Revenue, 2019-2030
6.5.2 China Extracellular Vesicle Therapy Market Size, 2019-2030
6.5.3 Japan Extracellular Vesicle Therapy Market Size, 2019-2030
6.5.4 South Korea Extracellular Vesicle Therapy Market Size, 2019-2030
6.5.5 Southeast Asia Extracellular Vesicle Therapy Market Size, 2019-2030
6.5.6 India Extracellular Vesicle Therapy Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Extracellular Vesicle Therapy Revenue, 2019-2030
6.6.2 Brazil Extracellular Vesicle Therapy Market Size, 2019-2030
6.6.3 Argentina Extracellular Vesicle Therapy Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Extracellular Vesicle Therapy Revenue, 2019-2030
6.7.2 Turkey Extracellular Vesicle Therapy Market Size, 2019-2030
6.7.3 Israel Extracellular Vesicle Therapy Market Size, 2019-2030
6.7.4 Saudi Arabia Extracellular Vesicle Therapy Market Size, 2019-2030
6.7.5 UAE Extracellular Vesicle Therapy Market Size, 2019-2030
7 Companies Profiles
7.1 FUJIFILM Diosynth Biotechnologies
7.1.1 FUJIFILM Diosynth Biotechnologies Corporate Summary
7.1.2 FUJIFILM Diosynth Biotechnologies Business Overview
7.1.3 FUJIFILM Diosynth Biotechnologies Extracellular Vesicle Therapy Major Product Offerings
7.1.4 FUJIFILM Diosynth Biotechnologies Extracellular Vesicle Therapy Revenue in Global Market (2019-2024)
7.1.5 FUJIFILM Diosynth Biotechnologies Key News & Latest Developments
7.2 EV Therapeutics
7.2.1 EV Therapeutics Corporate Summary
7.2.2 EV Therapeutics Business Overview
7.2.3 EV Therapeutics Extracellular Vesicle Therapy Major Product Offerings
7.2.4 EV Therapeutics Extracellular Vesicle Therapy Revenue in Global Market (2019-2024)
7.2.5 EV Therapeutics Key News & Latest Developments
7.3 Cellular Biomedicine Group
7.3.1 Cellular Biomedicine Group Corporate Summary
7.3.2 Cellular Biomedicine Group Business Overview
7.3.3 Cellular Biomedicine Group Extracellular Vesicle Therapy Major Product Offerings
7.3.4 Cellular Biomedicine Group Extracellular Vesicle Therapy Revenue in Global Market (2019-2024)
7.3.5 Cellular Biomedicine Group Key News & Latest Developments
7.4 Codiak BioSciences
7.4.1 Codiak BioSciences Corporate Summary
7.4.2 Codiak BioSciences Business Overview
7.4.3 Codiak BioSciences Extracellular Vesicle Therapy Major Product Offerings
7.4.4 Codiak BioSciences Extracellular Vesicle Therapy Revenue in Global Market (2019-2024)
7.4.5 Codiak BioSciences Key News & Latest Developments
7.5 Coya Therapeutics
7.5.1 Coya Therapeutics Corporate Summary
7.5.2 Coya Therapeutics Business Overview
7.5.3 Coya Therapeutics Extracellular Vesicle Therapy Major Product Offerings
7.5.4 Coya Therapeutics Extracellular Vesicle Therapy Revenue in Global Market (2019-2024)
7.5.5 Coya Therapeutics Key News & Latest Developments
7.6 Curexsys
7.6.1 Curexsys Corporate Summary
7.6.2 Curexsys Business Overview
7.6.3 Curexsys Extracellular Vesicle Therapy Major Product Offerings
7.6.4 Curexsys Extracellular Vesicle Therapy Revenue in Global Market (2019-2024)
7.6.5 Curexsys Key News & Latest Developments
7.7 Evox Therapeutics
7.7.1 Evox Therapeutics Corporate Summary
7.7.2 Evox Therapeutics Business Overview
7.7.3 Evox Therapeutics Extracellular Vesicle Therapy Major Product Offerings
7.7.4 Evox Therapeutics Extracellular Vesicle Therapy Revenue in Global Market (2019-2024)
7.7.5 Evox Therapeutics Key News & Latest Developments
7.8 ExoCoBio
7.8.1 ExoCoBio Corporate Summary
7.8.2 ExoCoBio Business Overview
7.8.3 ExoCoBio Extracellular Vesicle Therapy Major Product Offerings
7.8.4 ExoCoBio Extracellular Vesicle Therapy Revenue in Global Market (2019-2024)
7.8.5 ExoCoBio Key News & Latest Developments
7.9 ILIAS Biologics
7.9.1 ILIAS Biologics Corporate Summary
7.9.2 ILIAS Biologics Business Overview
7.9.3 ILIAS Biologics Extracellular Vesicle Therapy Major Product Offerings
7.9.4 ILIAS Biologics Extracellular Vesicle Therapy Revenue in Global Market (2019-2024)
7.9.5 ILIAS Biologics Key News & Latest Developments
7.10 Rion
7.10.1 Rion Corporate Summary
7.10.2 Rion Business Overview
7.10.3 Rion Extracellular Vesicle Therapy Major Product Offerings
7.10.4 Rion Extracellular Vesicle Therapy Revenue in Global Market (2019-2024)
7.10.5 Rion Key News & Latest Developments
7.11 SHIFTBIO
7.11.1 SHIFTBIO Corporate Summary
7.11.2 SHIFTBIO Business Overview
7.11.3 SHIFTBIO Extracellular Vesicle Therapy Major Product Offerings
7.11.4 SHIFTBIO Extracellular Vesicle Therapy Revenue in Global Market (2019-2024)
7.11.5 SHIFTBIO Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Extracellular Vesicle Therapy Market Opportunities & Trends in Global Market
Table 2. Extracellular Vesicle Therapy Market Drivers in Global Market
Table 3. Extracellular Vesicle Therapy Market Restraints in Global Market
Table 4. Key Players of Extracellular Vesicle Therapy in Global Market
Table 5. Top Extracellular Vesicle Therapy Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Extracellular Vesicle Therapy Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Extracellular Vesicle Therapy Revenue Share by Companies, 2019-2024
Table 8. Global Companies Extracellular Vesicle Therapy Product Type
Table 9. List of Global Tier 1 Extracellular Vesicle Therapy Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Extracellular Vesicle Therapy Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. Segmentation by Type – Global Extracellular Vesicle Therapy Revenue, (US$, Mn), 2023 & 2030
Table 12. Segmentation by Type - Global Extracellular Vesicle Therapy Revenue (US$, Mn), 2019-2024
Table 13. Segmentation by Type - Global Extracellular Vesicle Therapy Revenue (US$, Mn), 2025-2030
Table 14. Segmentation by Application– Global Extracellular Vesicle Therapy Revenue, (US$, Mn), 2023 & 2030
Table 15. Segmentation by Application - Global Extracellular Vesicle Therapy Revenue, (US$, Mn), 2019-2024
Table 16. Segmentation by Application - Global Extracellular Vesicle Therapy Revenue, (US$, Mn), 2025-2030
Table 17. By Region– Global Extracellular Vesicle Therapy Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Extracellular Vesicle Therapy Revenue, (US$, Mn), 2019-2024
Table 19. By Region - Global Extracellular Vesicle Therapy Revenue, (US$, Mn), 2025-2030
Table 20. By Country - North America Extracellular Vesicle Therapy Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Extracellular Vesicle Therapy Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Extracellular Vesicle Therapy Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Extracellular Vesicle Therapy Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Extracellular Vesicle Therapy Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Extracellular Vesicle Therapy Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Extracellular Vesicle Therapy Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Extracellular Vesicle Therapy Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Extracellular Vesicle Therapy Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Extracellular Vesicle Therapy Revenue, (US$, Mn), 2025-2030
Table 30. FUJIFILM Diosynth Biotechnologies Corporate Summary
Table 31. FUJIFILM Diosynth Biotechnologies Extracellular Vesicle Therapy Product Offerings
Table 32. FUJIFILM Diosynth Biotechnologies Extracellular Vesicle Therapy Revenue (US$, Mn) & (2019-2024)
Table 33. FUJIFILM Diosynth Biotechnologies Key News & Latest Developments
Table 34. EV Therapeutics Corporate Summary
Table 35. EV Therapeutics Extracellular Vesicle Therapy Product Offerings
Table 36. EV Therapeutics Extracellular Vesicle Therapy Revenue (US$, Mn) & (2019-2024)
Table 37. EV Therapeutics Key News & Latest Developments
Table 38. Cellular Biomedicine Group Corporate Summary
Table 39. Cellular Biomedicine Group Extracellular Vesicle Therapy Product Offerings
Table 40. Cellular Biomedicine Group Extracellular Vesicle Therapy Revenue (US$, Mn) & (2019-2024)
Table 41. Cellular Biomedicine Group Key News & Latest Developments
Table 42. Codiak BioSciences Corporate Summary
Table 43. Codiak BioSciences Extracellular Vesicle Therapy Product Offerings
Table 44. Codiak BioSciences Extracellular Vesicle Therapy Revenue (US$, Mn) & (2019-2024)
Table 45. Codiak BioSciences Key News & Latest Developments
Table 46. Coya Therapeutics Corporate Summary
Table 47. Coya Therapeutics Extracellular Vesicle Therapy Product Offerings
Table 48. Coya Therapeutics Extracellular Vesicle Therapy Revenue (US$, Mn) & (2019-2024)
Table 49. Coya Therapeutics Key News & Latest Developments
Table 50. Curexsys Corporate Summary
Table 51. Curexsys Extracellular Vesicle Therapy Product Offerings
Table 52. Curexsys Extracellular Vesicle Therapy Revenue (US$, Mn) & (2019-2024)
Table 53. Curexsys Key News & Latest Developments
Table 54. Evox Therapeutics Corporate Summary
Table 55. Evox Therapeutics Extracellular Vesicle Therapy Product Offerings
Table 56. Evox Therapeutics Extracellular Vesicle Therapy Revenue (US$, Mn) & (2019-2024)
Table 57. Evox Therapeutics Key News & Latest Developments
Table 58. ExoCoBio Corporate Summary
Table 59. ExoCoBio Extracellular Vesicle Therapy Product Offerings
Table 60. ExoCoBio Extracellular Vesicle Therapy Revenue (US$, Mn) & (2019-2024)
Table 61. ExoCoBio Key News & Latest Developments
Table 62. ILIAS Biologics Corporate Summary
Table 63. ILIAS Biologics Extracellular Vesicle Therapy Product Offerings
Table 64. ILIAS Biologics Extracellular Vesicle Therapy Revenue (US$, Mn) & (2019-2024)
Table 65. ILIAS Biologics Key News & Latest Developments
Table 66. Rion Corporate Summary
Table 67. Rion Extracellular Vesicle Therapy Product Offerings
Table 68. Rion Extracellular Vesicle Therapy Revenue (US$, Mn) & (2019-2024)
Table 69. Rion Key News & Latest Developments
Table 70. SHIFTBIO Corporate Summary
Table 71. SHIFTBIO Extracellular Vesicle Therapy Product Offerings
Table 72. SHIFTBIO Extracellular Vesicle Therapy Revenue (US$, Mn) & (2019-2024)
Table 73. SHIFTBIO Key News & Latest Developments
List of Figures
Figure 1. Extracellular Vesicle Therapy Product Picture
Figure 2. Extracellular Vesicle Therapy Segment by Type in 2023
Figure 3. Extracellular Vesicle Therapy Segment by Application in 2023
Figure 4. Global Extracellular Vesicle Therapy Market Overview: 2022
Figure 5. Key Caveats
Figure 6. Global Extracellular Vesicle Therapy Market Size: 2023 VS 2030 (US$, Mn)
Figure 7. Global Extracellular Vesicle Therapy Revenue: 2019-2030 (US$, Mn)
Figure 8. The Top 3 and 5 Players Market Share by Extracellular Vesicle Therapy Revenue in 2023
Figure 9. Segmentation by Type – Global Extracellular Vesicle Therapy Revenue, (US$, Mn), 2023 & 2030
Figure 10. Segmentation by Type - Global Extracellular Vesicle Therapy Revenue Market Share, 2019-2030
Figure 11. Segmentation by Application – Global Extracellular Vesicle Therapy Revenue, (US$, Mn), 2023 & 2030
Figure 12. Segmentation by Application - Global Extracellular Vesicle Therapy Revenue Market Share, 2019-2030
Figure 13. By Region - Global Extracellular Vesicle Therapy Revenue Market Share, 2019-2030
Figure 14. By Country - North America Extracellular Vesicle Therapy Revenue Market Share, 2019-2030
Figure 15. United States Extracellular Vesicle Therapy Revenue, (US$, Mn), 2019-2030
Figure 16. Canada Extracellular Vesicle Therapy Revenue, (US$, Mn), 2019-2030
Figure 17. Mexico Extracellular Vesicle Therapy Revenue, (US$, Mn), 2019-2030
Figure 18. By Country - Europe Extracellular Vesicle Therapy Revenue Market Share, 2019-2030
Figure 19. Germany Extracellular Vesicle Therapy Revenue, (US$, Mn), 2019-2030
Figure 20. France Extracellular Vesicle Therapy Revenue, (US$, Mn), 2019-2030
Figure 21. U.K. Extracellular Vesicle Therapy Revenue, (US$, Mn), 2019-2030
Figure 22. Italy Extracellular Vesicle Therapy Revenue, (US$, Mn), 2019-2030
Figure 23. Russia Extracellular Vesicle Therapy Revenue, (US$, Mn), 2019-2030
Figure 24. Nordic Countries Extracellular Vesicle Therapy Revenue, (US$, Mn), 2019-2030
Figure 25. Benelux Extracellular Vesicle Therapy Revenue, (US$, Mn), 2019-2030
Figure 26. By Region - Asia Extracellular Vesicle Therapy Revenue Market Share, 2019-2030
Figure 27. China Extracellular Vesicle Therapy Revenue, (US$, Mn), 2019-2030
Figure 28. Japan Extracellular Vesicle Therapy Revenue, (US$, Mn), 2019-2030
Figure 29. South Korea Extracellular Vesicle Therapy Revenue, (US$, Mn), 2019-2030
Figure 30. Southeast Asia Extracellular Vesicle Therapy Revenue, (US$, Mn), 2019-2030
Figure 31. India Extracellular Vesicle Therapy Revenue, (US$, Mn), 2019-2030
Figure 32. By Country - South America Extracellular Vesicle Therapy Revenue Market Share, 2019-2030
Figure 33. Brazil Extracellular Vesicle Therapy Revenue, (US$, Mn), 2019-2030
Figure 34. Argentina Extracellular Vesicle Therapy Revenue, (US$, Mn), 2019-2030
Figure 35. By Country - Middle East & Africa Extracellular Vesicle Therapy Revenue Market Share, 2019-2030
Figure 36. Turkey Extracellular Vesicle Therapy Revenue, (US$, Mn), 2019-2030
Figure 37. Israel Extracellular Vesicle Therapy Revenue, (US$, Mn), 2019-2030
Figure 38. Saudi Arabia Extracellular Vesicle Therapy Revenue, (US$, Mn), 2019-2030
Figure 39. UAE Extracellular Vesicle Therapy Revenue, (US$, Mn), 2019-2030
Figure 40. FUJIFILM Diosynth Biotechnologies Extracellular Vesicle Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 41. EV Therapeutics Extracellular Vesicle Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. Cellular Biomedicine Group Extracellular Vesicle Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. Codiak BioSciences Extracellular Vesicle Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. Coya Therapeutics Extracellular Vesicle Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. Curexsys Extracellular Vesicle Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. Evox Therapeutics Extracellular Vesicle Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. ExoCoBio Extracellular Vesicle Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. ILIAS Biologics Extracellular Vesicle Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 49. Rion Extracellular Vesicle Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 50. SHIFTBIO Extracellular Vesicle Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
